Surgical revascularization as a procedure to prevent neurological complications in children with moyamoya syndrome associated with neurofibromatosis I: a single institution case series.
Alberto MorelloMarcello ScalaIrene SchiavettiMaria Cristina DianaMariasavina SeverinoDomenico TortoraGianluca PiatelliMarco PavanelloPublished in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2024)
Currently, whether combined or indirect bypass should be considered the treatment of choice in pediatric patients with NF1-associated MMS remains unclear, as well as the optimal time approach. In our series, no significant differences were found in long-term neurocognitive outcome and stroke rate between patients treated with either of these two approaches. Clinical evidence supports the crucial role of early diagnosis and surgical revascularization in subjects with MMS-associated NF1, even in case of mildly symptomatic vasculopathy. This allows to achieve a good long-term outcome with improved intellectual function and prevention of stroke and seizure in these patients.
Keyphrases
- atrial fibrillation
- end stage renal disease
- signaling pathway
- lps induced
- percutaneous coronary intervention
- newly diagnosed
- ejection fraction
- oxidative stress
- chronic kidney disease
- coronary artery bypass grafting
- nuclear factor
- pi k akt
- risk factors
- prognostic factors
- peritoneal dialysis
- minimally invasive
- cerebral ischemia
- case report
- acute coronary syndrome
- cell proliferation
- inflammatory response
- brain injury
- combination therapy
- subarachnoid hemorrhage